Ventripoint Diagnostics Stock Market Value
| VPTDF Stock | USD 0.1 0.01 5.00% |
| Symbol | VentriPoint |
VentriPoint Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VentriPoint Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VentriPoint Diagnostics.
| 12/06/2025 |
| 01/05/2026 |
If you would invest 0.00 in VentriPoint Diagnostics on December 6, 2025 and sell it all today you would earn a total of 0.00 from holding VentriPoint Diagnostics or generate 0.0% return on investment in VentriPoint Diagnostics over 30 days. VentriPoint Diagnostics is related to or competes with Biotricity, Aurora Spine, and Luff Enterprises. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patien... More
VentriPoint Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VentriPoint Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VentriPoint Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.89 | |||
| Information Ratio | 0.1015 | |||
| Maximum Drawdown | 31.88 | |||
| Value At Risk | (8.20) | |||
| Potential Upside | 12.59 |
VentriPoint Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VentriPoint Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VentriPoint Diagnostics' standard deviation. In reality, there are many statistical measures that can use VentriPoint Diagnostics historical prices to predict the future VentriPoint Diagnostics' volatility.| Risk Adjusted Performance | 0.0883 | |||
| Jensen Alpha | 0.5846 | |||
| Total Risk Alpha | 0.1974 | |||
| Sortino Ratio | 0.1297 | |||
| Treynor Ratio | 0.3635 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VentriPoint Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VentriPoint Diagnostics Backtested Returns
VentriPoint Diagnostics appears to be out of control, given 3 months investment horizon. VentriPoint Diagnostics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0833, which indicates the firm had a 0.0833 % return per unit of risk over the last 3 months. By inspecting VentriPoint Diagnostics' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please review VentriPoint Diagnostics' Semi Deviation of 4.37, coefficient of variation of 892.39, and Risk Adjusted Performance of 0.0883 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, VentriPoint Diagnostics holds a performance score of 6. The entity has a beta of 1.9, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, VentriPoint Diagnostics will likely underperform. Please check VentriPoint Diagnostics' maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to make a quick decision on whether VentriPoint Diagnostics' existing price patterns will revert.
Auto-correlation | 0.05 |
Virtually no predictability
VentriPoint Diagnostics has virtually no predictability. Overlapping area represents the amount of predictability between VentriPoint Diagnostics time series from 6th of December 2025 to 21st of December 2025 and 21st of December 2025 to 5th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VentriPoint Diagnostics price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current VentriPoint Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
VentriPoint Diagnostics lagged returns against current returns
Autocorrelation, which is VentriPoint Diagnostics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VentriPoint Diagnostics' pink sheet expected returns. We can calculate the autocorrelation of VentriPoint Diagnostics returns to help us make a trade decision. For example, suppose you find that VentriPoint Diagnostics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VentriPoint Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VentriPoint Diagnostics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VentriPoint Diagnostics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VentriPoint Diagnostics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
VentriPoint Diagnostics Lagged Returns
When evaluating VentriPoint Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VentriPoint Diagnostics pink sheet have on its future price. VentriPoint Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VentriPoint Diagnostics autocorrelation shows the relationship between VentriPoint Diagnostics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in VentriPoint Diagnostics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in VentriPoint Pink Sheet
VentriPoint Diagnostics financial ratios help investors to determine whether VentriPoint Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.